Biotech startup Moderna Therapeutics snags $110 mln

Moderna Therapeutics has closed $110 million in financing round. The names of the investors have not been disclosed but Flagship Ventures does have a stake in the company. Based in Cambridge, Mass., Moderna Therapeutics is a biotech startup that is developing messenger RNA drugs.

20 November 2013•3 mins read
Feature image
LinkedInXEmail
LinkedInXEmail